Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Structural features of subtype-selective EP receptor modulatorsMarkovič, Tijana ; Jakopin, Žiga ; Dolenc, Marija Sollner ; Mlinarič-Raščan, IrenaDrug discovery today, 2017-01, Vol.22 (1), p.57-71 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
2 |
Material Type: Artigo
|
International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progressWoodward, D F ; Jones, R L ; Narumiya, SPharmacological reviews, 2011-09, Vol.63 (3), p.471-538 [Periódico revisado por pares]United StatesTexto completo disponível |
|
3 |
Material Type: Artigo
|
Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulationHata, Aaron N ; Breyer, Richard MPharmacology & therapeutics (Oxford), 2004-08, Vol.103 (2), p.147-166 [Periódico revisado por pares]EnglandTexto completo disponível |
|
4 |
Material Type: Artigo
|
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and InhibitionSimmons, Daniel L ; Botting, Regina M ; Hla, TimothyPharmacological reviews, 2004-09, Vol.56 (3), p.387-437 [Periódico revisado por pares]United States: American Society for Pharmacology and Experimental TherapeuticsTexto completo disponível |
|
5 |
Material Type: Artigo
|
Prostaglandin E2 EP receptors in cardiovascular disease: An updateBryson, Timothy D. ; Harding, PamelaBiochemical pharmacology, 2022-01, Vol.195, p.114858-114858, Article 114858 [Periódico revisado por pares]England: Elsevier IncTexto completo disponível |
|
6 |
Material Type: Artigo
|
Small‐molecule inhibition of prostaglandin E receptor 2 impairs cyclooxygenase‐associated malignant glioma growthQiu, Jiange ; Li, Qianqian ; Bell, Katherine A. ; Yao, Xue ; Du, Yifeng ; Zhang, Erik ; Yu, Jane J. ; Yu, Ying ; Shi, Zhi ; Jiang, JianxiongBritish journal of pharmacology, 2019-06, Vol.176 (11), p.1680-1699 [Periódico revisado por pares]England: Blackwell Publishing LtdTexto completo disponível |
|
7 |
Material Type: Artigo
|
Deleterious effects of cardiomyocyte-specific prostaglandin E2 EP3 receptor overexpression on cardiac function after myocardial infarctionMaxwell, DruAnne L. ; Bryson, Timothy D. ; Taube, David ; Xu, Jiang ; Peterson, Edward ; Harding, PamelaLife sciences (1973), 2023-01, Vol.313, p.121277-121277, Article 121277 [Periódico revisado por pares]Netherlands: Elsevier IncTexto completo disponível |
|
8 |
Material Type: Artigo
|
Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical EfficacySykes, David A ; Bradley, Michelle E ; Riddy, Darren M ; Willard, Elizabeth ; Reilly, John ; Miah, Asadh ; Bauer, Carsten ; Watson, Simon J ; Sandham, David A ; Dubois, Gerald ; Charlton, Steven JMolecular pharmacology, 2016-05, Vol.89 (5), p.593-605 [Periódico revisado por pares]United StatesTexto completo disponível |
|
9 |
Material Type: Artigo
|
What about COVID-19 and arachidonic acid pathway?Hoxha, MalvinaEuropean journal of clinical pharmacology, 2020-11, Vol.76 (11), p.1501-1504 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
|
10 |
Material Type: Artigo
|
Pharmacologic profile of OC000459, a potent, selective, and orally active D prostanoid receptor 2 antagonist that inhibits mast cell-dependent activation of T helper 2 lymphocytes and eosinophilsPettipher, Roy ; Vinall, Shân L ; Xue, Luzheng ; Speight, Graham ; Townsend, Elizabeth R ; Gazi, Lucien ; Whelan, Cliff J ; Armer, Richard E ; Payton, Mark A ; Hunter, Michael GThe Journal of pharmacology and experimental therapeutics, 2012-02, Vol.340 (2), p.473-482 [Periódico revisado por pares]United StatesTexto completo disponível |